Purdue pharma pleads guilty over role in U.S. opioid epidemic

Purdue pharma pleads guilty over role in U.S. opioid epidemic

(HealthDay)—Purdue Pharma pleaded guilty to three criminal charges linked to the Oxycontin maker's role in the nation's opioid epidemic.

In a virtual hearing Tuesday with a in Newark, New Jersey, Purdue admitted that it paid doctors to write more prescriptions for the company's painkillers and paid an electronic medical records company to give doctors information on patients that encouraged the prescribing of opioids, the Associated Press reported.

Under a deal with the Justice Department, the company also admitted to providing misleading information to the U.S. Drug Enforcement Administration. The deal includes $8.3 billion in penalties and forfeitures, but Purdue would pay only $225 million to the as long as it reaches a settlement with state and local governments and other agencies suing the company over the opioid crisis, the AP reported.

Purdue is owned by the Sackler family, who have agreed to pay $225 million to the federal government to settle civil claims. No family members face criminal charges, but their agreement does not prevent that from happening in the future, the AP reported.


Explore further

Purdue Pharma pleads guilty to criminal charges over opioid sales

More information: AP News Article

Copyright © 2020 HealthDay. All rights reserved.

Citation: Purdue pharma pleads guilty over role in U.S. opioid epidemic (2020, November 26) retrieved 22 January 2021 from https://medicalxpress.com/news/2020-11-purdue-pharma-guilty-role-opioid.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
7 shares

Feedback to editors

User comments